Impaired Activation of NFκB in T Cells From a Subset of Renal Cell Carcinoma Patients Is Mediated by Inhibition of Phosphorylation and Degradation of the Inhibitor, IκB
- 15 August 1998
- journal article
- Published by American Society of Hematology in Blood
- Vol. 92 (4) , 1334-1341
- https://doi.org/10.1182/blood.v92.4.1334
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Variable expression of CD3‐ζ chain in tumor‐infiltrating lymphocytes (TIL) derived from renal‐cell carcinoma: Relationship with til phenotype and functionInternational Journal of Cancer, 1995
- Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor‐infiltrating lymphocytesInternational Journal of Cancer, 1995
- The IκB proteins: members of a multifunctional familyTrends in Genetics, 1993
- NF-κB Subunit Regulation in Nontransformed CD4 + T LymphocytesScience, 1992
- B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50Cell, 1991
- Modulation of T-cell function by gliomasImmunology Today, 1991
- DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptideCell, 1991
- Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsalCell, 1990
- The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene productCell, 1990
- Transmission of Signals from the T Lymphocyte Antigen Receptor to the Genes Responsible for Cell Proliferation and Immune Function: The Missing LinkAnnual Review of Immunology, 1990